CX Institutional
TEVA icon

CX Institutional’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

CX Institutional’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,600
Closed -$54K – 1733
2026
Q2 		$54K Buy
+1,600
New +$53.3K ﹤0.01% 970
2019
Q1 		– Sell
-245
Closed -$4K – 821
2018
Q4 		$4K Buy
245
+5
+2% +$103 ﹤0.01% 412
2018
Q3 		$5K Hold
240
– – ﹤0.01% 293
2018
Q2 		$6K Buy
+240
New +$4.89K ﹤0.01% 259

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
CA
Continental Advisors Park City, Utah $233M AUM 14.5% 1-Year Est. Return
Burford Brothers
Burford Brothers Dallas, Texas $275M AUM 18.76% 1-Year Est. Return
Oak Harvest Investment Services
Oak Harvest Investment Services Houston, Texas $1.07B AUM 32.83% 1-Year Est. Return

CX Institutional's TEVA Position: Q3 2026 in Review

CX Institutional sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 1,600 shares — an estimated $54K sold.

CX Institutional first reported a position in TEVA in Q2 2018 and held it in 4 quarters. The position peaked at $54K in Q2 2026. 81 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • CX Institutional reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
  • CX Institutional sold 1,600 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $54K.
  • CX Institutional first reported a position in Teva Pharmaceutical Industries Limited in Q2 2018 and held it in 4 quarters.
  • CX Institutional's Teva Pharmaceutical Industries Limited position peaked at $54K in Q2 2026.
  • 81 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.